From: Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
HH+HR
RR
Total
Null(%)
8.9
26.3
13.3
Moderate(%)
27.8
15.8
25.5
Good(%)
63.3
57.9
62.2
